» Articles » PMID: 34198720

Effect of Infant and Maternal Secretor Status on Rotavirus Vaccine Take-An Overview

Overview
Journal Viruses
Publisher MDPI
Specialty Microbiology
Date 2021 Jul 2
PMID 34198720
Citations 5
Authors
Affiliations
Soon will be listed here.
Abstract

Histo-blood group antigens, which are present on gut epithelial surfaces, function as receptors or attachment factors and mediate susceptibility to rotavirus infection. The major determinant for susceptibility is a functional FUT2 enzyme which mediates the presence of α-1,2 fucosylated blood group antigens in mucosa and secretions, yielding the secretor-positive phenotype. Secretors are more susceptible to infection with predominant rotavirus genotypes, as well as to the commonly used live rotavirus vaccines. Difference in susceptibility to the vaccines is one proposed factor for the varying degree of efficacy observed between countries. Besides infection susceptibility, secretor status has been found to modulate rotavirus specific antibody levels in adults, as well as composition of breastmilk in mothers and microbiota of the infant, which are other proposed factors affecting rotavirus vaccine take. Here, the known and possible effects of secretor status in both infant and mother on rotavirus vaccine take are reviewed and discussed.

Citing Articles

Geographic disparities impacting oral vaccine performance: Observations and future directions.

Burke R, Ramani S, Lynch J, Cooper L, Cho H, Bandyopadhyay A Clin Exp Immunol. 2025; 219(1).

PMID: 39774633 PMC: 11773816. DOI: 10.1093/cei/uxae124.


Infant Non-Secretor Histoblood Group Antigen Phenotype Reduces Susceptibility to Both Symptomatic and Asymptomatic Rotavirus Infection.

Lee B, Kader M, Alam M, Dickson D, Harvey P, Colgate E Pathogens. 2024; 13(3).

PMID: 38535566 PMC: 10974866. DOI: 10.3390/pathogens13030223.


Maternal and Infant Histo-Blood Group Antigen (HBGA) Profiles and Their Influence on Oral Rotavirus Vaccine (Rotarix) Immunogenicity among Infants in Zambia.

Chauwa A, Bosomprah S, Laban N, Phiri B, Chibuye M, Chilyabanyama O Vaccines (Basel). 2023; 11(8).

PMID: 37631871 PMC: 10458424. DOI: 10.3390/vaccines11081303.


Maternal Breast Milk Secretor Phenotype Does Not Affect Infant Susceptibility to Rotavirus Diarrhea.

Williams F, Kader M, Dickson D, Colgate E, Alam M, Haque R Open Forum Infect Dis. 2023; 10(6):ofad299.

PMID: 37333724 PMC: 10270652. DOI: 10.1093/ofid/ofad299.


Vaccinomics: A scoping review.

Dudley M, Gerber J, Budigan Ni H, Blunt M, Holroyd T, Carleton B Vaccine. 2023; 41(14):2357-2367.

PMID: 36803903 PMC: 10065969. DOI: 10.1016/j.vaccine.2023.02.009.


References
1.
Appaiahgari M, Glass R, Singh S, Taneja S, Rongsen-Chandola T, Bhandari N . Transplacental rotavirus IgG interferes with immune response to live oral rotavirus vaccine ORV-116E in Indian infants. Vaccine. 2013; 32(6):651-6. DOI: 10.1016/j.vaccine.2013.12.017. View

2.
Williams F, Kader A, Colgate E, Dickson D, Carmolli M, Uddin M . Maternal Secretor Status Affects Oral Rotavirus Vaccine Response in Breastfed Infants in Bangladesh. J Infect Dis. 2020; 224(7):1147-1151. PMC: 8561252. DOI: 10.1093/infdis/jiaa101. View

3.
Matamoros S, Gras-Leguen C, Le Vacon F, Potel G, de La Cochetiere M . Development of intestinal microbiota in infants and its impact on health. Trends Microbiol. 2013; 21(4):167-73. DOI: 10.1016/j.tim.2012.12.001. View

4.
Moon S, Tate J, Ray P, Dennehy P, Archary D, Coutsoudis A . Differential profiles and inhibitory effect on rotavirus vaccines of nonantibody components in breast milk from mothers in developing and developed countries. Pediatr Infect Dis J. 2013; 32(8):863-70. PMC: 4610365. DOI: 10.1097/INF.0b013e318290646d. View

5.
Newburg D, Ruiz-Palacios G, Altaye M, Chaturvedi P, Meinzen-Derr J, de Lourdes Guerrero M . Innate protection conferred by fucosylated oligosaccharides of human milk against diarrhea in breastfed infants. Glycobiology. 2003; 14(3):253-63. DOI: 10.1093/glycob/cwh020. View